Involvement of CRAF1, a relative of TRAF, in CD40 signaling

Science

Volumn 267, Issue 5203, 1995, Pages 1494-1498

  Cheng, Genhong ^a   Cleary, Aileen M ^b   Ye, Zheng Sheng ^c   Hong, David I ^b   Lederman, Seth ^b   Baltimore, David ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE ANTIGEN; CD23 ANTIGEN; CD40 ANTIGEN; LYMPHOCYTE MEMBRANE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; ZINC FINGER PROTEIN;

ANIMAL CELL; ARTICLE; CELL SURVIVAL; DIMERIZATION; HUMAN; HUMAN CELL; IMMUNOGENETICS; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DIFFERENTIATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 0028936733     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.7533327     Document Type: Article

References (57)

1. S. Paulie et al., Cancer Immunol. Immunother. 20, 23 (1985); E. A. Clark and J. A. Ledbetter, Proc. Natl. Acad. Sci. U.S.A. 83, 4494 (1986); I. Stamenkovic, E. A. Clark, B. Seed, EMBO J. 8, 1403 (1989).
2. S. Paulie et al., Cancer Immunol. Immunother. 20, 23 (1985); E. A. Clark and J. A. Ledbetter, Proc. Natl. Acad. Sci. U.S.A. 83, 4494 (1986); I. Stamenkovic, E. A. Clark, B. Seed, EMBO J. 8, 1403 (1989).
3. S. Paulie et al., Cancer Immunol. Immunother. 20, 23 (1985); E. A. Clark and J. A. Ledbetter, Proc. Natl. Acad. Sci. U.S.A. 83, 4494 (1986); I. Stamenkovic, E. A. Clark, B. Seed, EMBO J. 8, 1403 (1989).
4. S. Lederman et al., J. Exp. Med. 175, 1091 (1992); R. J. Armitage et al., Nature 357, 80 (1992); D. Graf, U. Korthauer, H. W. Mages, G. Senger, R. A. Kroczek, Eur. J. Immunol. 22, 3191 (1992); J. F. Gauchat et al., FEBS Lett. 315, 259 (1993).
5. S. Lederman et al., J. Exp. Med. 175, 1091 (1992); R. J. Armitage et al., Nature 357, 80 (1992); D. Graf, U. Korthauer, H. W. Mages, G. Senger, R. A. Kroczek, Eur. J. Immunol. 22, 3191 (1992); J. F. Gauchat et al., FEBS Lett. 315, 259 (1993).
6. S. Lederman et al., J. Exp. Med. 175, 1091 (1992); R. J. Armitage et al., Nature 357, 80 (1992); D. Graf, U. Korthauer, H. W. Mages, G. Senger, R. A. Kroczek, Eur. J. Immunol. 22, 3191 (1992); J. F. Gauchat et al., FEBS Lett. 315, 259 (1993).
7. S. Lederman et al., J. Exp. Med. 175, 1091 (1992); R. J. Armitage et al., Nature 357, 80 (1992); D. Graf, U. Korthauer, H. W. Mages, G. Senger, R. A. Kroczek, Eur. J. Immunol. 22, 3191 (1992); J. F. Gauchat et al., FEBS Lett. 315, 259 (1993).
8. S. Lederman et al., J. Immunol. 149, 3817 (1992).
9. D. Hollenbaugh et al., EMBO J. 11, 4313 (1992).
10. T. Tsubata, J. Wu, T. Honjo, Nature 364, 645 (1993); N. J. Holder et al., Eur. J. Immunol. 23, 2368 (1993); S. L. Parry, J. Hasbold, M. Holman, G. G. B. Klaus J. Immunol. 152, 2821 (1994); A. M. Cleary, S. M. Fortune, L. Chess, S. Lederman, unpublished results.
11. T. Tsubata, J. Wu, T. Honjo, Nature 364, 645 (1993); N. J. Holder et al., Eur. J. Immunol. 23, 2368 (1993); S. L. Parry, J. Hasbold, M. Holman, G. G. B. Klaus J. Immunol. 152, 2821 (1994); A. M. Cleary, S. M. Fortune, L. Chess, S. Lederman, unpublished results.
12. T. Tsubata, J. Wu, T. Honjo, Nature 364, 645 (1993); N. J. Holder et al., Eur. J. Immunol. 23, 2368 (1993); S. L. Parry, J. Hasbold, M. Holman, G. G. B. Klaus J. Immunol. 152, 2821 (1994); A. M. Cleary, S. M. Fortune, L. Chess, S. Lederman, unpublished results.
13. T. Tsubata, J. Wu, T. Honjo, Nature 364, 645 (1993); N. J. Holder et al., Eur. J. Immunol. 23, 2368 (1993); S. L. Parry, J. Hasbold, M. Holman, G. G. B. Klaus J. Immunol. 152, 2821 (1994); A. M. Cleary, S. M. Fortune, L. Chess, S. Lederman, unpublished results.
14. M. J. Yellin et al., J. Immunol. 153, 666 (1994).
15. R. C. Allen et al., Science 259, 990 (1993); U. Korthauer et al., Nature 361, 539 (1993); J. P. Di-Santo et al., ibid., p. 541; A. Aruffo et al., Cell 72, 291 (1993); R. E. Callard et al., J. Immunol. 153, 3295 (1994); N. Ramesh et al., Int. Immunol. 5, 769 (1993).
16. R. C. Allen et al., Science 259, 990 (1993); U. Korthauer et al., Nature 361, 539 (1993); J. P. Di-Santo et al., ibid., p. 541; A. Aruffo et al., Cell 72, 291 (1993); R. E. Callard et al., J. Immunol. 153, 3295 (1994); N. Ramesh et al., Int. Immunol. 5, 769 (1993).
17. R. C. Allen et al., Science 259, 990 (1993); U. Korthauer et al., Nature 361, 539 (1993); J. P. Di-Santo et al., ibid., p. 541; A. Aruffo et al., Cell 72, 291 (1993); R. E. Callard et al., J. Immunol. 153, 3295 (1994); N. Ramesh et al., Int. Immunol. 5, 769 (1993).
18. R. C. Allen et al., Science 259, 990 (1993); U. Korthauer et al., Nature 361, 539 (1993); J. P. Di-Santo et al., ibid., p. 541; A. Aruffo et al., Cell 72, 291 (1993); R. E. Callard et al., J. Immunol. 153, 3295 (1994); N. Ramesh et al., Int. Immunol. 5, 769 (1993).
19. R. C. Allen et al., Science 259, 990 (1993); U. Korthauer et al., Nature 361, 539 (1993); J. P. Di-Santo et al., ibid., p. 541; A. Aruffo et al., Cell 72, 291 (1993); R. E. Callard et al., J. Immunol. 153, 3295 (1994); N. Ramesh et al., Int. Immunol. 5, 769 (1993).
20. R. C. Allen et al., Science 259, 990 (1993); U. Korthauer et al., Nature 361, 539 (1993); J. P. Di-Santo et al., ibid., p. 541; A. Aruffo et al., Cell 72, 291 (1993); R. E. Callard et al., J. Immunol. 153, 3295 (1994); N. Ramesh et al., Int. Immunol. 5, 769 (1993).
21. J. Xu et al., Immunity 1, 423 (1994).
22. T. Kawabe et al., ibid., p. 167.
23. F. Schrieve et al., J. Exp. Med. 169, 2043 (1989); E. A. Clark, K. H. Grabstein, G. L. Shu, J. Immunol. 148, 3327 (1992).
24. F. Schrieve et al., J. Exp. Med. 169, 2043 (1989); E. A. Clark, K. H. Grabstein, G. L. Shu, J. Immunol. 148, 3327 (1992).
25. D. N. Hart and J.L. McKenzie, J. Exp. Med. 168, 157 (1988).
26. M. R. Alderson et al., ibid. 178, 669 (1993).
27. A. H. Galy and H. Spits, J. Immunol. 149, 775 (1992).
28. F. H. Durie, T. M. Foy, S. R. Masters, J. D. Laman, R. J. Noelle, Immunol. Today 15, 406 (1994).
29. S. Inui et al., Eur. J. Immunol. 20, 1747 (1990).
30. The bait for the yeast two-hybrid screen was a LexA fusion protein containing the cytoplasmic tail of the mouse CD40 receptor (from residue 219 to the COOH-terminus).
31. 5 individual clones, with an average insert size of 0.9 kb.
32. G. Cheng, Z. S. Ye, D. Baltimore, unpublished results.
33. M. Rothe, S. C. Wong, W. J. Henzel, D. V. Goeddel, Cell 78, 681 (1994).
34. W. H. Landschulz, P. F. Johnson, S. L. McKnight, Science 240, 1759 (1988).
35. R. M. Evans and S. M. Hollenberg, Cell 52, 1 (1988).
36. Abbreviations for the amino acid residues are A, Ala; C, Cys; D, Asp; E, Glu; F, Phe; G, Gly; H, His; I, lle; K, Lys; L, Leu; M, Met; N, Asn; P, Pro; Q, Gln; R, Arg; S, Ser; T, Thr; V, Val; W, Trp; and Y, Tyr.
37. P. S. Fremont, I. M. Hanson, J. Trowsdale, ibid. 64, 483 (1991).
38. P. N. Barlow, B. Luisi, A. Milner, M. Elliott, R. Everett, J. Mol. Biol. 237, 201 (1994).
39. J. P. Siegel and H. S. Mostowski, J. Immunol. Methods 132, 287 (1990).
40. The C26 cDNA fragment was cut with Eco RI-Hinc III from yeast vector YSD, ligated into Bluescript IISK+ (Stratagene), and then recloned in-frame into the pEBVHisA vector (Invitrogen), with the use of Bam HI and Kpn I cuts, to create pEBVHis/C26. Stable Ramos cell lines containing either this construct or the control construct (pEBVHis/lacZ) were isolated by electroporation and hygromycin selection.
41. 4 293.CD40L. cells. In some cases, mAb 5C8 (anti-CD40L) was added. Cells were then washed and incubated with saturating concentrations of mAb Leu-16 (anti-CD20) conjugated to fluorescein isothiocyanate (Becton Dickinson) and mAb to CD23 conjugated to phycoerythrin (Biosource International) for 45 min at 4°C in the presence of heat-aggregated IgG (80 μg/ml) (International Enzyme). Cells were washed to remove unbound antibody before fluorescence intensity was measured on a FACSCAN cytofluorograph (Becton Dickinson) with Consort 30 software.
42. C. A. Smith, T. Farrah, R. G. Goodwin, Cell 76, 959 (1994).
43. N. Itoh et al., ibid. 66, 233 (1991); L. A. Taraglis, T. M. Ayres, G. H. W. Wong, D. V. Goeddel. ibid. 74, 845 (1993).
44. N. Itoh et al., ibid. 66, 233 (1991); L. A. Taraglis, T. M. Ayres, G. H. W. Wong, D. V. Goeddel. ibid. 74, 845 (1993).
45. M. Grilli, J. J.-S. Chiu, M. J. Lenardo, Int. Rev. Cytol. 143, 1 (1991); I. Berberich, G. L. Shu, E. A. Clark, J. Immunol. 153, 4357 (1994).
46. M. Grilli, J. J.-S. Chiu, M. J. Lenardo, Int. Rev. Cytol. 143, 1 (1991); I. Berberich, G. L. Shu, E. A. Clark, J. Immunol. 153, 4357 (1994).
47. J. Gordon, M. J. Millsum, G. R. Guy, J. A. Ledbetter, J. Immunol. 140, 1425 (1988); M. F. Gruber, J. M. Bjorndahl, S. Nakamuar, S. M. Fu, ibid. 142, 4144 (1989); M. K. Spriggs et al., J. Exp. Med. 176, 1543 (1992); P. Lane et al., ibid. 177, 1209 (1993); D. H. Crawford and D. Catovsky, Immunology 80, 40 (1993); A. W. Heath et al., Cell Immunol. 152, 468 (1993); Y.-J. Liu et al., Nature 342, 929 (1989).
48. J. Gordon, M. J. Millsum, G. R. Guy, J. A. Ledbetter, J. Immunol. 140, 1425 (1988); M. F. Gruber, J. M. Bjorndahl, S. Nakamuar, S. M. Fu, ibid. 142, 4144 (1989); M. K. Spriggs et al., J. Exp. Med. 176, 1543 (1992); P. Lane et al., ibid. 177, 1209 (1993); D. H. Crawford and D. Catovsky, Immunology 80, 40 (1993); A. W. Heath et al., Cell Immunol. 152, 468 (1993); Y.-J. Liu et al., Nature 342, 929 (1989).
49. J. Gordon, M. J. Millsum, G. R. Guy, J. A. Ledbetter, J. Immunol. 140, 1425 (1988); M. F. Gruber, J. M. Bjorndahl, S. Nakamuar, S. M. Fu, ibid. 142, 4144 (1989); M. K. Spriggs et al., J. Exp. Med. 176, 1543 (1992); P. Lane et al., ibid. 177, 1209 (1993); D. H. Crawford and D. Catovsky, Immunology 80, 40 (1993); A. W. Heath et al., Cell Immunol. 152, 468 (1993); Y.-J. Liu et al., Nature 342, 929 (1989).
50. J. Gordon, M. J. Millsum, G. R. Guy, J. A. Ledbetter, J. Immunol. 140, 1425 (1988); M. F. Gruber, J. M. Bjorndahl, S. Nakamuar, S. M. Fu, ibid. 142, 4144 (1989); M. K. Spriggs et al., J. Exp. Med. 176, 1543 (1992); P. Lane et al., ibid. 177, 1209 (1993); D. H. Crawford and D. Catovsky, Immunology 80, 40 (1993); A. W. Heath et al., Cell Immunol. 152, 468 (1993); Y.-J. Liu et al., Nature 342, 929 (1989).
51. J. Gordon, M. J. Millsum, G. R. Guy, J. A. Ledbetter, J. Immunol. 140, 1425 (1988); M. F. Gruber, J. M. Bjorndahl, S. Nakamuar, S. M. Fu, ibid. 142, 4144 (1989); M. K. Spriggs et al., J. Exp. Med. 176, 1543 (1992); P. Lane et al., ibid. 177, 1209 (1993); D. H. Crawford and D. Catovsky, Immunology 80, 40 (1993); A. W. Heath et al., Cell Immunol. 152, 468 (1993); Y.-J. Liu et al., Nature 342, 929 (1989).
52. J. Gordon, M. J. Millsum, G. R. Guy, J. A. Ledbetter, J. Immunol. 140, 1425 (1988); M. F. Gruber, J. M. Bjorndahl, S. Nakamuar, S. M. Fu, ibid. 142, 4144 (1989); M. K. Spriggs et al., J. Exp. Med. 176, 1543 (1992); P. Lane et al., ibid. 177, 1209 (1993); D. H. Crawford and D. Catovsky, Immunology 80, 40 (1993); A. W. Heath et al., Cell Immunol. 152, 468 (1993); Y.-J. Liu et al., Nature 342, 929 (1989).
53. J. Gordon, M. J. Millsum, G. R. Guy, J. A. Ledbetter, J. Immunol. 140, 1425 (1988); M. F. Gruber, J. M. Bjorndahl, S. Nakamuar, S. M. Fu, ibid. 142, 4144 (1989); M. K. Spriggs et al., J. Exp. Med. 176, 1543 (1992); P. Lane et al., ibid. 177, 1209 (1993); D. H. Crawford and D. Catovsky, Immunology 80, 40 (1993); A. W. Heath et al., Cell Immunol. 152, 468 (1993); Y.-J. Liu et al., Nature 342, 929 (1989).
54. H. M. Hu, K, O'Rourke, M. S. Boguski, V. M. Dixit, J. Biol. Chem. 269, 30069 (1994).
55. G. Mosialos et al., Cell 80, 389 (1995).
56. J. H. Miller, in Experiments in Molecular Genetics, C. S. H. L. Press, Ed. (Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, 1972).
57. We thank P. Svec and T. Hawkins for their help in sequencing and J. Jacob for critical reading of the manuscript. G.G. and Z.-Y. are recipients of an Irvington House Institute fellowship and a Leukemia Society special fellowship, respectively. S.L. is an Arthritis Investigator of the Arthritis Foundation. D.B. is an American Cancer Society Research Professor. A.M.C. is supported by the Medical Scientist Training Program grant 5-T32-GM07367. S.L., A.M.C., and D.I.H. are also supported in part by Biogen, Cambridge, MA. This work was supported by National Institute of Allergy and Infectious Diseases grant A122346 (D.B.) and by National Cancer Institute (NCI) grant R01-CA55713 to S.L.